Increased Cyclooxygenase-2-Derived Prostanoids Contributes to the Hyperreactivity to Noradrenaline in Mesenteric Resistance Arteries from Offspring of Diabetic Rats

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Ramos Alves, Fernanda E ^a   de Queiroz, Diego B ^a   Santos Rocha, Juliana ^a   Duarte, Gloria P ^a   Xavier, Fabiano E ^a  

^a DEPARTAMENTO DE MICOLOGIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

11 FLUORO 9,15 DIHYDROXY 15 (2 INDANYL) 16,17,18,19,20 PENTANORPROSTA 5,13 DIENOIC ACID; 5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; 6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; CYCLOOXYGENASE 2; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NORADRENALIN; PROSTAGLANDIN E2; PROSTAGLANDIN E2ALPHA; PROSTANOID; STREPTOZOCIN; THROMBOXANE A2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY RESISTANCE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; FEMALE; HYPERACTIVITY; INCUBATION TIME; MATERNAL DIABETES MELLITUS; MESENTERIC RESISTANCE ARTERY; NONHUMAN; PATHOGENESIS; PREGNANCY; PROGENY; RAT;

ANIMALS; CELLS, CULTURED; CYCLOOXYGENASE 2; DIABETES MELLITUS, EXPERIMENTAL; DINOPROST; ENDOTHELIAL CELLS; FEMALE; IMMUNOENZYME TECHNIQUES; INDOMETHACIN; MALE; MESENTERIC ARTERIES; NITROBENZENES; NOREPINEPHRINE; PREGNANCY; PROSTAGLANDINS; PROSTAGLANDINS E; PROSTAGLANDINS F; RATS; SULFONAMIDES; THROMBOXANE A2; XANTHONES;

RATTUS;

EID: 84870358555     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050593     Document Type: Article

References (49)

1. Nehiri T, Duong Van Huyen JP, Viltard M, Fassot C, Heudes D, et al. (2008) Exposure to maternal diabetes induces salt-sensitive hypertension and impairs renal function in adult rat offspring. Diabetes 57: 2167-2175.
2. Segar EM, Norris AW, Yao JR, Hu S, Koppenhafer SL, et al. (2010) Programming of growth, insulin resistance and vascular dysfunction in offspring of late gestation diabetic rats. Clin Sci 117: 129-138.
3. Simeoni U, Barker DJ, (2009) Offspring of diabetic pregnancy: Long-term outcomes. Seminars in Fetal & Neo Med 14: 119-124.
4. Chen YW, Chenier I, Tran S, Scotcher M, Chang SY, et al. (2010) Maternal diabetes programs hypertension and kidney injury in offspring. Pediatr Nephrol 25: 1319-1329.
5. Blondeau B, Joly B, Perret C, Prince S, Bruneval P, et al. (2011) Exposure in utero to maternal diabetes leads to glucose intolerance and high blood pressure with no major effects on lipid metabolism. Diabetes Metab 37: 245-251.
6. Barker DJ, Eriksson JG, Forsén T, Osmond C, (2002) Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 31: 1235-1239.
7. Barker DJ, (2004) The developmental origins of adult disease. J Am Col Nutr 23: 588-595.
8. Rocha SO, Gomes GN, Forti AL, Franco MC, Fortes ZB, et al. (2005) Long-term effects of maternal diabetes on vascular reactivity and renal function in the rat male offspring. Pediatr Res 58: 1274-1279.
9. Ramos-Alves FE, de Queiroz DB, Santos-Rocha J, Duarte GP, Xavier FE, (2012) Effect of age and cyclooxygenase-2-derived prostanoids on the progression of adult vascular dysfunction in offspring diabetic rats. Br J Pharmacol 166: 2198-2208.
10. Wichi RB, Souza SB, Casarini DE, Morris M, Barreto-Chaves ML, et al. (2005) Fetal Physiological Programming Increased blood pressure in the offspring of diabetic mothers. Am J Physiol Regul Integr Comp Physiol 288: 1129-1133.
11. Amri K, Freund N, Vilar J, Merlet-Bénichou C, Lelièvre-Pégorier M, (1999) Adverse effects of hyperglycemia on kidney development in rats: in vivo and in vitro studies. Diabetes 48: 2240-2245.
12. Holemans K, Gerber RT, Meurrens K, de Clerck F, Poston L, et al. (1999) Streptozotocin diabetes in the pregnant rat induces cardiovascular dysfunction in adult offspring. Diabetologia 42: 81-89.
13. Félétou M, Huang Y, Vanhoutte PM, (2011) Endothelium-mediated control of vascular tone: COX-1 and COX-2 products. Br J Pharmacol 164: 894-912.
14. Helmersson J, Vessby B, Larsson A, Basu S, (2004) Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population. Circulation 109: 1729-1734.
15. Alvarez Y, Briones AM, Balfagón G, Alonso MJ, Salaices M, (2005) Hypertension increases the participation of vasoconstrictor prostanoids from cyclooxygenase-2 in phenylephrine responses. J Hypertens 23: 767-777.
16. Bagi Z, Erdei N, Toth A, Li W, Hintze TH, et al. (2005) Type 2 diabetic mice have increased arteriolar tone and blood pressure: enhanced release of COX-2-derived constrictor prostaglandins. Arterioscler Thromb Vasc Biol 25: 1610-1616.
17. Blanco-Rivero J, Cachofeiro V, Lahera V, Aras-Lopez R, Marquez-Rodas I, et al. (2005) Participation of prostacyclin in endothelial dysfunction induced by aldosterone in normotensive and hypertensive rats. Hypertension 46: 107-112.
18. Shi Y, Vanhoutte PM, (2008) Oxidative stress and COX cause hyper-responsiveness in vascular smooth muscle of the femoral artery from diabetic rats. Br J Pharmacol 154: 639-651.
19. Xavier FE, Aras-López R, Arroyo-Villa I, Campo LD, Salaices M, et al. (2008) Aldosterone induces endothelial dysfunction in resistance arteries from normotensive and hypertensive rats by increasing thromboxane A2 and prostacyclin. Br J Pharmacol 154: 1225-1235.
20. Virdis A, Colucci R, Versari D, Ghisu N, Fornai M, et al. (2009) Atorvastatin prevents endothelial dysfunction in mesenteric arteries from spontaneously hypertensive rats: role of cyclooxygenase 2-derived contracting prostanoids. Hypertension 53: 1008-1016.
21. Xavier FE, Blanco-Rivero J, Avendaño MS, Sastre E, Yela R, et al. (2011) Aldosterone alters the participation of endothelial factors in noradrenaline vasoconstriction differently in resistance arteries from normotensive and hypertensive rats. Eur J Pharmacol 654: 280-288.
22. Diederich D, Yang ZH, Bühler FR, Lüscher TF, (1990) Impaired endothelium-dependent relaxations in hypertensive resistance arteries involve cyclooxygenase pathway. Am J Physiol 258: H445-451.
23. Mulvany MJ, Halpern W, (1977) Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 41: 19-26.
24. Fetita LS, Sobngwi E, Serradas P, Calvo F, Gautier JF, (2006) Consequences of fetal exposure to maternal diabetes in offspring. J Clin Endocrinol Metab 91: 3718-3724.
25. Ingram DA, Lien IZ, Mead LE, Estes M, Prater DN, et al. (2008) In vitro hyperglycemia or a diabetic intrauterine environment reduces neonatal endothelial colony-forming cell numbers and function. Diabetes 57: 724-731.
26. Dohi Y, Kojima M, Sato K, (1996) Endothelial modulation of contractile responses in arteries from hypertensive rats. Hypertension 28: 732-737.
27. Wang D, Iversen J, Strandgaard S, (1999) Contractility and endothelium-dependent relaxation of resistance vessels in polycystic kidney disease rats. J Vasc Res 36: 502-509.
28. Matsumoto T, Miyamori K, Kobayashi T, Kamata K, (2006) Apocynin normalizes hyperreactivity to phenylephrine in mesenteric arteries from cholesterol-fed mice by improving endothelium-derived hyperpolarizing factor response. Free Radic Biol Med 41: 1289-1303.
29. Lagaud GJ, Masih-Khan E, Kai S, van Breemen C, Dube GP, (2001) Influence of type II diabetes on arterial tone and endothelial function in murine mesenteric resistance arteries. J Vasc Res 38: 578-589.
30. Xavier FE, Davel AP, Rossoni LV, Vassallo DV, (2003) Time-dependent hyperreactivity to phenylephrine in aorta from untreated diabetic rats: role of prostanoids and calcium mobilization. Vascul Pharmacol 40: 67-76.
31. Guo Z, Su W, Allen S, Pang H, Daugherty A, et al. (2005) COX-2 up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice. Cardiovasc Res 67: 723-735.
32. Wenceslau CF, Davel AP, Xavier FE, Rossoni LV, (2011) Long-term ouabain treatment impairs vascular function in resistance arteries. J Vasc Res 48: 316-326.
33. Parente L, Perretti M, (2003) Advances in the pathophysiology of constitutive and inducible cyclooxygenases: two enzymes in the spotlight. Biochem Pharmacol 65: 153-159.
34. Elmarakby AA, Imig JD, (2010) Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diet hypertensive rats. Clin Sci 118: 291-301.
35. Retailleau K, Belin de Chantemèle EJ, Chanoine S, Guihot AL, Vessières E, et al. (2010) Reactive oxygen species and cyclooxygenase 2-derived thromboxane A2 reduce angiotensin II type 2 receptor vasorelaxation in diabetic rat resistance arteries. Hypertension 55: 339-344.
36. Shiokoshi T, Ohsaki Y, Kawabe J, Fujino T Kikuchi K, (2002) Downregulation of nitric oxide accumulation by cyclooxygenase-2 induction and thromboxane A2 production in interleukin-1beta-stimulated rat aortic smooth muscle cells. J Hypertens 20: 455-461.
37. Peçanha FM, Wiggers GA, Briones AM, Perez-Giron JV, Miguel M, et al. (2010) The role of cyclooxygenase (COX)-2 derived prostanoids on vasoconstrictor responses to phenylephrine is increased by exposure to low mercury concentration. J Physiol Pharmacol 61: 29-36.
38. Rutkai I, Feher A, Erdei N, Henrion D, Papp Z, et al. (2009) Activation of prostaglandin E2 EP1 receptor increases arteriolar tone and blood pressure in mice with type 2 diabetes. Cardiovasc Res 83: 148-154.
39. Guan Y, Zhang Y, Wu J, Qi Z, Yang G, et al. (2007) Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting. J Clin Invest 117: 2496-2505.
40. Himmelstein SI, Klotman PE, (1989) The role of thromboxane in two-kidney, one-clip Goldblatt hypertension in rats. Am J Physiol 257: F190-196.
41. Boussairi EH, Sacquet J, Sassard J, Benzoni D, (1994) Thromboxane A2-prostaglandin H2 and renovascular hypertension in rats. Am J Physiol 267: R1190-1197.
42. Francois H, Makhanova N, Ruiz P, Ellison J, Mao L, et al. (2008) A role for the thromboxane receptor in L-NAME hypertension. Am J Physiol Renal Physiol 295: 1096-1102.
43. Kawada N, Dennehy K, Solis G, Modlinger P, Hamel R, et al. (2004) TP receptors regulate renal hemodynamics during angiotensin II slow pressor response. Am J Physiol Renal Physiol 287: 753-759.
44. Tian X, Wong WT, Leung FP, Zhang Y, Wang YX, et al. (2011) Oxidative Stress-dependent Cyclooxygenase-2-derived Prostaglandin F2α Impairs Endothelial Function in Renovascular Hypertensive Rats. Antioxid Redox Signal 16: 363-373.
45. Yu Y, Lucitt MB, Stubbe J, Cheng Y, Friis UG, et al. (2009) Prostaglandin F2alpha elevates blood pressure and promotes atherosclerosis. Proc Natl Acad Sci USA 106: 7985-7990.
46. Félétou M, Köhler R, Vanhoutte PM, (2010) Endothelium-derived vasoactive factors and hypertension: possible roles in pathogenesis and as treatment targets. Curr Hypertens Rep 12: 267-275.
47. Bohr DF, Webb RC, (1984) Vascular smooth muscle function and its changes in hypertension. Am J Med 77: 3-16.
48. Kishi K, Inoue T, (1990) Possible mechanisms of abnormal norepinephrine sensitivity and reactivity of resistance vessels and the development of hypertension in spontaneously hypertensive rats. A hypothesis. Am J Hypertens 3: 202-205.
49. dos Santos L, Xavier FE, Vassallo DV, Rossoni LV, (2003) Cyclooxygenase pathway is involved in the vascular reactivity and inhibition of the Na+, K+-ATPase activity in the tail artery from L-NAME-treated rats. Life Sci 74: 613-627.